DR. ALISON ELIZABETH BAIRD, MBBS
Neurology in Brooklyn, NY
License number
New York 248616
Category
Neurology
Type
Neurology
Address
Address
450 Suny Downstate Medical Ctr, Brooklyn, NY 11203
Phone
(718) 221-5188
(718) 221-5761 (Fax)
(718) 221-5761 (Fax)
Personal information
See more information about ALISON ELIZABETH BAIRD at radaris.comName
Address
Phone
99 Joralemon St APT 5B, Brooklyn, NY 11201
Brooklyn, NY
50 72Nd St, New York, NY 10023
99 Joralemon St, Brooklyn, NY 11201
50 72Nd St, New York, NY 10023
Professional information
Alison E Baird, Bethesda MD
Specialties:
Neurology, Internal Medicine
Address:
VALID FOR US CIVIL SERVICE EMPLOYEE ON
10 Ctr Dr, Bethesda 20892
(301) 496-0207 (Phone)
Suny Downstate Med Ctr Nrlgy
450 Clarkson Ave SUITE 1274, Brooklyn 11203
(718) 221-5188 (Phone)
10 Ctr Dr, Bethesda 20892
(301) 496-0207 (Phone)
Suny Downstate Med Ctr Nrlgy
450 Clarkson Ave SUITE 1274, Brooklyn 11203
(718) 221-5188 (Phone)
Languages:
English
Education:
Medical School
University of Medicine And Dentistry of New Jersey / Newark
Graduated: 2009
University of Medicine And Dentistry of New Jersey / Newark
Graduated: 2009
Differential Expression Of Molecules Associated With Intra-Cerebral Hemorrhage
US Patent:
2010008, Apr 8, 2010
Filed:
Jul 11, 2007
Appl. No.:
12/307910
Inventors:
Alison E. Baird - Brooklyn NY, US
David F. Moore - Rockville MD, US
Ehud Goldin - Rockville MD, US
Kory Johnson - Rockville MD, US
David F. Moore - Rockville MD, US
Ehud Goldin - Rockville MD, US
Kory Johnson - Rockville MD, US
International Classification:
C12Q 1/68, C40B 40/06, C40B 40/10, A61K 49/00
US Classification:
424 91, 435 6, 506 16, 506 18
Abstract:
Methods are provided for evaluating a stroke, for example for determining whether a subject has had a hemorrhagic stroke, determining the severity or likely neurological recovery of a subject who has had a hemorrhagic stroke, and determining a treatment regimen for a subject who has had a hemorrhagic stroke, as are arrays and kits that can be used to practice the methods. In particular examples, the method includes screening for expression of hemorrhagic stroke related genes (or proteins), such as genes (or proteins) involved in suppression of the immune response, genes (or proteins) involved in vascular repair, genes (or proteins) involved in the acute inflammatory response, genes (or proteins) involved in cell adhesion, genes (or proteins) involved in hypoxia, genes (or proteins) involved in signal transduction, and genes (or proteins) involved in the response to the altered cerebral microenvironment. Arrays and kits are provided that can be used in the disclosed methods. Also provided are methods of identifying one or more agents that alter the activity (such as the expression) of a hemorrhagic stroke-related molecule.